D. E. Shaw & Co., Inc. Calyxt, Inc. Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.25 - $12.01 $197,795 - $558,945	-46,540 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.21 - $5.68 $49,562 - $87,699	-15,440 Reduced 24.91%	46,540 $196,000
Q3 2020 Nov 16, 2020	BUY	$4.37 - $7.66 $56,831 - $99,618	13,005 Added 26.55%	61,980 $340,000
Q2 2020 Aug 14, 2020	SELL	$2.9 - $6.36 $3,181 - $6,976	-1,097 Reduced 2.19%	48,975 $241,000
Q1 2020 May 15, 2020	SELL	$2.48 - $7.85 $4,126 - $13,062	-1,664 Reduced 3.22%	50,072 $167,000
Q4 2019 Feb 14, 2020	BUY	$3.6 - $7.27 $186,249 - $376,120	51,736 New	51,736 $363,000
Q4 2017 Feb 14, 2018	SELL	$17.13 - $31.48 $299,535 - $550,459	-17,486 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.82 - $28.31 $206,684 - $495,028	17,486	17,486 $428,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.